Physician profile
Soluny Jean
NPI 1427544121
$501.54
in general payments reported to CMS, 2019-2025
10 companies · $144 in 2025
The $144 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $199 · 2022: $18.07 · 2023: $37.16 · 2024: $103 · 2025: $144.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $284.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $284.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $137.39 | 2021 | |
| Stryker Corporation | $98.68 | 2025 | Flowtriever, Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Novartis Pharmaceuticals Corporation | $68.98 | 2022-2024 | |
| Inari Medical, INC. | $50.48 | 2023-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Pfizer INC. | $46.00 | 2024-2025 | |
| Mallinckrodt Hospital Products INC. | $33.78 | 2021 | |
| Atricure, INC. | $21.99 | 2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $16.32 | 2025 | Lifevest |
| Gilead Sciences, INC. | $14.58 | 2021 | |
| Abbvie INC. | $13.34 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Soluny Jean listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.